한국줄기세포표준의학연구원, 파마메틱스(Pharmametics), 보떼베니(Béauté Bénie), 재생의공학

Natural Science-affiliated Korea Stem Cell Standard Medical Institute (Director Ph.Dr. Jung Kikwan) is accelerating its global expansion through its flagship brand Béauté Bénie.

On October 30, 2022, the institute established a Pharmametics production plant in Cheongbuk, Pyeongtaek, Gyeonggi Province, marking the beginning of a new phase of growth. Founded in 2013 at Seoul National University’s Pyeongchang Campus, the institute later relocated to Pyeongtaek, where it continues to operate today.

Béauté Bénie is pursuing global franchise development with two core business lines:

• Stem cell-based medical devices targeting natural aesthetic procedures

• Pharmametics regenerative medicine leveraging stem cell technologies for reverse aging and holistic beauty

The brand emphasizes not superficial beauty but reverse aging through Stemcell Assembloid technology, aiming to deliver “a new dimension of regenerative medicine experience” to customers.

The first flagship store in Seoul’s metropolitan area will serve as a launchpad for overseas expansion, particularly in post-COVID global markets.

Director Ph.Dr Jung stated, “We are currently active in eight countries, but we aim to strengthen sales promotion and grow Béauté Bénie into a world-class brand.

With our extensive B2B experience, we will expand franchises step by step and secure diverse distribution channels through Pharmametics to enhance brand power.”

---

Technology Strategy

Béauté Bénie’s technology strategy is anchored in advanced science:

• Fusion innovation:

Combining stem cell regenerative medicine with medical devices to achieve natural aesthetics and reverse aging

• Continuous R&D investment:

Strengthening research capabilities at the Pyeongtaek plant to meet global standards

• Quality assurance:

Establishing internationally certified quality systems for credibility in global markets

• Digital healthcare integration:

Linking medical devices with IT solutions to deliver personalized care

---

Global Franchise Strategy

Béauté Bénie will officially launch its franchise business in September 2024, with ambitious goals set for 2030.

• European foothold:

Establishing Amsterdam, Netherlands, as the gateway to Europe

• Asian market expansion:

Strengthening presence across Asia to capture emerging demand

• Franchise growth:

Securing 20 franchise locations across 12 countries by the end of 2030

• Revenue target:

Achieving $4 million in sales by 2030

• Localized strategies:

Tailoring products and services to the medical environment and consumer needs of each region

---

The institute’s main business areas include dermatology, plastic surgery, regenerative medicine, orthopedics, and ophthalmology. Its core product portfolio spans medical equipment, medical devices, and Pharmametics.

Note:

Pharmametics is a compound of Pharmacy + Cosmetics.

---